Credit Suisse’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
NAMA
Credit Suisse's TWST Position: Q1 2024 in Review
Credit Suisse reduced its Twist Bioscience (TWST) stake by 0.2% in Q1 2024, selling an estimated $105K and leaving 1,420,633 shares worth $48.7M. The position accounts for 0.05% of the portfolio, ranked #380.
Credit Suisse first reported a position in TWST in Q3 2019 and has held it in 19 quarters since. The position peaked at $190M in Q2 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.
- Credit Suisse held 1,420,633 shares of Twist Bioscience worth $48.7M as of Q1 2024.
- Credit Suisse sold 2,901 Twist Bioscience shares in Q1 2024, an estimated $105K.
- Twist Bioscience made up 0.05% of Credit Suisse's portfolio in Q1 2024, its #380 holding.
- Credit Suisse first reported a position in Twist Bioscience in Q3 2019 and has held it in 19 quarters since.
- Credit Suisse's Twist Bioscience position peaked at $190M in Q2 2021.
- 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.